ARTIS Ventures

ARTIS Ventures ("AV") is an active San Francisco-based venture capital firm founded in 2001 that pioneered the "TechBio" investment thesis—funding early-stage startups at the intersection of computer science and life sciences. They back data-driven life sciences and healthcare technology companies globally with scalable medical technologies aimed at improving health outcomes or curing disease. Their investments span therapeutics discovery/development platforms (e.g., gene/cell therapies), diagnostics/AI-enabled tools for clinicians/radiologists/surgeons/labs/trials management software as well as digital health delivery models. The firm has supported notable exits such as Stemcentrx (acquired by AbbVie) and Lemonaid Health (acquired by 23andMe).